RxDoctor Payments Data

Jessen Mukalel, MD

Interventional Pain Medicine · Conroe, TXNPI 1336397280

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (56.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Genesys Orthopedics Systems, L.L.C. accounts for 87.0% of it on its own, with 30 other manufacturers making up the rest. Among interventional pain medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$70,189in general payments, 2019–2025

Across 393 payments — averaging $178.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genesys Orthopedics Systems, L.L.C.$61K
  • Abbott$5K
  • Relievant Medsystems, Inc.$859
  • Teva Pharmaceuticals USA, Inc.$658
  • Biodelivery Sciences International, Inc.$429
  • Painteq LLC$369
  • plus $2K from 25 others

What the payments were for

  • Royalty or licence$39,41456%
  • Consulting fees$19,00027%
  • Travel & lodging$1,8233%
  • Food & beverage$9,90714%
  • Gifts$450%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$70,189 in reported general payments places this provider in the 90th percentile of 287 interventional pain medicine providers in Texas.

See all interventional pain medicine providers in Texas

Medicare billing

Part B allowed, 2024
$323,273
Medicare patients
195
Services billed
2,148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl28$19,443
Lidocaine47$3,269
Pregabalin79$1,202
Naproxen129$807
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen37$520
Amitriptyline Hcl84$511
Tizanidine Hcl46$172
Gabapentin19$151
Acetaminophen-CodeineAcetaminophen With Codeine33$146
Ibuprofen12$111
Oxycodone Hcl18$94
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim48$78
Methylprednisolone14$63
Tramadol Hcl13$48

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Conroe

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →